Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)
Multiplex Assay Kit for Cross Linked N-Telopeptide Of Type I Collagen (NTXI) ,etc. by FLIA (Flow Luminescence Immunoassay)
NTX-I; NTX1
(注:單次混測多因子不超過8個指標(biāo) )
- 編號LMA639Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法競爭抑制
- 反應(yīng)時長1.5h
- 檢測范圍0.2-200ng/mL
- 靈敏度最小可檢測劑量小于等于0.067 ng/mL.
- 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 8指標(biāo)數(shù) 7指標(biāo)數(shù) 6指標(biāo)數(shù) 5指標(biāo)數(shù) 4指標(biāo)數(shù) 3指標(biāo)數(shù) 2指標(biāo)數(shù)1指標(biāo)數(shù)
- 價格 ¥ 2359 ¥ 2449 ¥ 2586 ¥ 2767 ¥ 2948 ¥ 3221 ¥ 3629 計算器 ¥ 4536 添加到價格計算器
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 91-101 | 97 |
EDTA plasma(n=5) | 97-105 | 101 |
heparin plasma(n=5) | 79-102 | 83 |
sodium citrate plasma(n=5) | 88-96 | 92 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-101% | 93-101% | 79-102% | 79-94% |
EDTA plasma(n=5) | 96-103% | 84-99% | 99-105% | 78-94% |
heparin plasma(n=5) | 99-105% | 95-102% | 95-102% | 88-99% |
sodium citrate plasma(n=5) | 92-103% | 83-91% | 84-91% | 81-101% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標(biāo)準(zhǔn)品、試劑及樣本準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品、樣本、磁珠、檢測溶液A)標(biāo)準(zhǔn)品或樣本50μL及磁珠10μL,加檢測溶液A50μL,
37°C酶標(biāo)板振蕩器孵育60分鐘;
3. 磁吸洗板3次;
4. 加檢測溶液B100μL,37°C振動孵育30分鐘;
5. 磁吸洗板3次;
6. 加鞘液100μL,旋渦震蕩2分鐘后讀數(shù)。
實驗原理
將Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體包被于磁珠,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本以及磁珠、標(biāo)記VEGFA,標(biāo)記的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)和未標(biāo)記的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體競爭結(jié)合,然后將未結(jié)合物洗凈后,加入PE標(biāo)記的親和素,再次徹底洗滌后即可上機讀數(shù)。MFI值和樣品中的Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法)呈負相關(guān)。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
SPA639Hu01 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)合成多肽 | Immunogen; Blocking Peptide. |
CPA639Hu11 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)牛血清白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
CPA639Hu21 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA639Hu01 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)多克隆抗體 | WB; IHC; ICC; IP. |
LAA639Hu61 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)多克隆抗體(吲哚菁綠標(biāo)記) | IHC; ICC; IP. |
MAA639Hu21 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu22 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu23 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu24 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu25 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
MAA639Hu28 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體 | WB; IHC; ICC; IP. |
LAA639Hu84 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)單克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
CEA639Hu | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA639Hu | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA639Hu11 | Ⅰ型膠原交聯(lián)氨基端肽(NTXI)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Nutrition | Dyslipidemic high-fat diet affects adversely bone metabolism in mice associated with impaired antioxidant capacity [ScienceDirect: S0899900709004717] |
Bone | Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet [ScienceDirect: S875632820800776X] |
Journal of Orthopaedic Research | Promotion of bone formation by naringin in a titanium particle‐induced diabetic murine calvarial osteolysis model [Wiley: Source] |
The Journal of Clinical Endocrinology & Metabolism | A Mediterranean Diet Enriched with Olive Oil Is Associated with Higher Serum Total Osteocalcin Levels in Elderly Men at High Cardiovascular Risk [PubMed: PMC3462931] |
Acta Paediatr.? | Biochemical markers of bone resorption are present in human milk: implications for maternal and neonatal bone metabolism [Pubmed:25109232] |
PLoS One. | An NMR Metabolomic Study on the Effect of Alendronate in Ovariectomized Mice [Pubmed:25184758] |
J Bone Miner Res | Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta [PubMed: 26679066] |
Journal of Functional Foods | Comparative effects of brown and golden flaxseeds on body composition, inflammation and bone remodelling biomarkers in perimenopausal overweight women [S1756464617301561] |
Archives?of?Oral?Biology | Impact?of a?chronic?smoking?habit?on the?osteo-immunoinflammatory?mediators?in the?peri-implant?fluid?of?clinically?healthy?dental?implants. [pubmed:27328151] |
Journal of Periodontology | Impact of a triclosan‐containing toothpaste during the progression of experimental peri‐implant mucositis: Clinical parameters and local pattern of osteo?… [Pubmed:29520826] |
Clinical?oral?implants?research | Triclosan‐containing fluoride toothpaste on clinical parameters and osteo‐inflammatory mediators when applied in a stent during experimental peri‐implant mucositis?… [Pubmed: 30659666] |
Molecular Therapy-Nucleic Acids | AAV-anti-miR-214 prevents collapse of the femoral head in osteonecrosis by regulating osteoblast and osteoclast activities [Pubmed: 31739209] |
Bioengineering (Basel) | Material-Dependent Formation and Degradation of Bone Matrix—Comparison of Two Cryogels [Pubmed: 32517006] |
BioMed Research International | Comparable Effects of Strontium Ranelate and Alendronate Treatment on Fracture Reduction in a Mouse Model of Osteogenesis Imperfecta [33506016] |
PHARMACEUTICAL BIOLOGY | Effects of icariin on the fracture healing in young and old rats and its mechanism [34511043] |
Evid Based Complement Alternat Med | Gujiansan Ameliorates Avascular Necrosis of the Femoral Head by Regulating Autophagy via the HIF-1α/BNIP3 Pathway [34512780] |